165 related articles for article (PubMed ID: 25725107)
1. IL-1 receptor type 2 suppresses collagen-induced arthritis by inhibiting IL-1 signal on macrophages.
Shimizu K; Nakajima A; Sudo K; Liu Y; Mizoroki A; Ikarashi T; Horai R; Kakuta S; Watanabe T; Iwakura Y
J Immunol; 2015 Apr; 194(7):3156-68. PubMed ID: 25725107
[TBL] [Abstract][Full Text] [Related]
2. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice.
Hata H; Sakaguchi N; Yoshitomi H; Iwakura Y; Sekikawa K; Azuma Y; Kanai C; Moriizumi E; Nomura T; Nakamura T; Sakaguchi S
J Clin Invest; 2004 Aug; 114(4):582-8. PubMed ID: 15314695
[TBL] [Abstract][Full Text] [Related]
3. Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions.
Pou J; Martínez-González J; Rebollo A; Rodríguez C; Rodríguez-Calvo R; Martín-Fuentes P; Cenarro A; Civeira F; Laguna JC; Alegret M
Biochim Biophys Acta; 2011 Sep; 1811(9):556-63. PubMed ID: 21683158
[TBL] [Abstract][Full Text] [Related]
4. Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory Responses.
Martin P; Palmer G; Rodriguez E; Seemayer CA; Palomo J; Talabot-Ayer D; Gabay C
J Immunol; 2017 Apr; 198(7):2916-2926. PubMed ID: 28235865
[TBL] [Abstract][Full Text] [Related]
5. SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
Drexler SK; Kong P; Inglis J; Williams RO; Garlanda C; Mantovani A; Yazdi AS; Brennan F; Feldmann M; Foxwell BM
Arthritis Rheum; 2010 Aug; 62(8):2249-61. PubMed ID: 20506350
[TBL] [Abstract][Full Text] [Related]
6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
7. Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions.
Martin P; Palmer G; Vigne S; Lamacchia C; Rodriguez E; Talabot-Ayer D; Rose-John S; Chalaris A; Gabay C
J Leukoc Biol; 2013 Oct; 94(4):791-802. PubMed ID: 23817563
[TBL] [Abstract][Full Text] [Related]
8. ADAM17 regulates IL-1 signaling by selectively releasing IL-1 receptor type 2 from the cell surface.
Uchikawa S; Yoda M; Tohmonda T; Kanaji A; Matsumoto M; Toyama Y; Horiuchi K
Cytokine; 2015 Feb; 71(2):238-45. PubMed ID: 25461404
[TBL] [Abstract][Full Text] [Related]
9. IL-12p35 promotes antibody-induced joint inflammation by activating NKT cells and suppressing TGF-beta.
Park Y; Kim HS; Ahn JY; Yun D; Cho ML; Hong S; Kim HY; Chung DH
J Immunol; 2010 Aug; 185(3):1476-84. PubMed ID: 20581146
[TBL] [Abstract][Full Text] [Related]
10. Ectopic expression of interleukin-1 receptor type II enhances cell migration through activation of the pre-interleukin 1alpha pathway.
Chang SY; Su PF; Lee TC
Cytokine; 2009 Jan; 45(1):32-8. PubMed ID: 19026558
[TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
[TBL] [Abstract][Full Text] [Related]
12. Murine tumor necrosis factor α-induced adipose-related protein (tumor necrosis factor α-induced protein 9) deficiency leads to arthritis via interleukin-6 overproduction with enhanced NF-κB, STAT-3 signaling, and dysregulated apoptosis of macrophages.
Inoue A; Matsumoto I; Tanaka Y; Umeda N; Tanaka Y; Mihara M; Takahashi S; Sumida T
Arthritis Rheum; 2012 Dec; 64(12):3877-85. PubMed ID: 22886597
[TBL] [Abstract][Full Text] [Related]
13. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis.
Bessis N; Guéry L; Mantovani A; Vecchi A; Sims JE; Fradelizi D; Boissier MC
Eur J Immunol; 2000 Mar; 30(3):867-75. PubMed ID: 10741403
[TBL] [Abstract][Full Text] [Related]
14. Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model.
Pils MC; Pisano F; Fasnacht N; Heinrich JM; Groebe L; Schippers A; Rozell B; Jack RS; Müller W
Eur J Immunol; 2010 Feb; 40(2):443-8. PubMed ID: 19941312
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin 1 and interleukin 2 in rat and mouse arthritis models.
Phadke K; Carlson DG; Gitter BD; Butler LD
J Immunol; 1986 Jun; 136(11):4085-91. PubMed ID: 3486226
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D
Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482
[TBL] [Abstract][Full Text] [Related]
18. Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice.
Kagari T; Tanaka D; Doi H; Iwakura Y; Shimozato T
Eur J Immunol; 2007 Oct; 37(10):2753-63. PubMed ID: 17823985
[TBL] [Abstract][Full Text] [Related]
19. Regulation of IL-1 signaling by the decoy receptor IL-1R2.
Schlüter T; Schelmbauer C; Karram K; Mufazalov IA
J Mol Med (Berl); 2018 Oct; 96(10):983-992. PubMed ID: 30109367
[TBL] [Abstract][Full Text] [Related]
20. Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.
Oelmann E; Stein H; Berdel WE; Herbst H
PLoS One; 2015; 10(9):e0138747. PubMed ID: 26406983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
